EXAI(Delisted)
ExscientiaยทNASDAQ
--
--(--)
EXAI Profile
Exscientia Limited
A artificial intelligence-driven pharmtech platform for drug design, discovery, and development
--
06/29/2021
10/01/2021
NASDAQ Stock Exchange
483
12-31
Depository Receipts (Ordinary Shares)
The Schrodinger Building, Oxford Science Park, Oxford OX4 4GE, United Kingdom
--
Exscientia Limited was incorporated on 29 June 2021 under the laws of England and Wales. The company is an artificial intelligence-driven pharmaceutical technology company dedicated to discovering, designing and developing the best medicines in the fastest and most effective way. The company's goal is to change the essential pharmacoeconomic model of the pharmaceutical industry by improving the probability, time and cost of success, which they call the "change curve. ". The company has built complete artificial intelligence end-to-end solutions, as well as experimental technologies for target identification, drug candidate design, translational models, and patient selection. The company's platform enables them to design drug candidate molecules that have entered clinical trials and prospectively provide patients with potentially more applicable drug therapies through AI-guided evaluation.
